Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications

Vaccine

Volumn 19, Issue 15-16, 2001, Pages 1837-1848

  Hilleman, Maurice R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Chemotherapeutic; Cirrhosis; Hepatitis B virus; Hepatocarcinoma; T cells

Indexed keywords

CYTOKINE; LAMIVUDINE; RECOMBINANT ALPHA INTERFERON;

CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER CANCER; LIVER CIRRHOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VIRUS MUTATION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; GENOME, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; MUTATION; VACCINATION;

EID: 0035961542     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00364-9     Document Type: Review

References (83)

1. The hepatitis alphabet - Hepatitis A-G and TTV
2. TTV virus
3. News and Views, New hepatitis virus discovered
4. Identification of hepatitis B virus indigenous to chimpanzees
5. Full genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: Implications for an origin of HBV
6. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): Phylogenetic relationships with human and other primate genotypes
7. Hepatitis B virus
8. Hepadnaviridae and their replication
9. Hepatitis B virus replication: Novel roles for virus-host interactions
10. Membrane structure of the hepatitis B virus surface antigen particle
11. Evolutionary relationship between hepadnaviruses and retroviruses
12. Hepadnaviruses and retroviruses share genome homology and features of replication
13. Comparative biology and pathogenesis of AIDS and hepatitis B viruses. Related but different
14. Recombination between sequences of hepatitis B virus from different genotypes
15. Relationships between genotypes of hepatitis B virus at points across the genome: Footprints of recombination in certain isolates
16. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness
17. The immunobiology of viral hepatitis
18. Hepatitis B virus biology
19. The immunopathogenesis of hepatitis B virus infection
20. Hepatitis B virus infection
21. Naturally occurring variants of hepatitis B virus
22. Intrahepatic T cells in hepatitis B: Viral control versus liver cell injury
23. Hepatitis B virus mutants
24. Hepatitis viruses: Genetic variants and clinical significance
25. Clinical relevance of hepatitis B viral mutations
26. Hepatitis B virus mutants in HBsAg positive children
27. Human hepatitis B mutants; significance of molecular changes
28. Hepatitis B virus transgenic mice: Models of viral immunobiology and pathogenesis
29. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
30. b mice in utero
31. Infection of the fetus with hepatitis B e antigen via the placenta
32. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: A mechanism for persistence
33. Do T cells see the hepatitis B core and e antigens differently?
34. The secretory protein of human hepatitis B virus is expressed on the cell surface
35. Hepatitis B virus in transgenic mice: Insights into the virus and the disease
36. Viral clearance without destruction of infected cells during acute HBV infection
37. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice
38. Viruses, immunity, and cancer: Lessons from hepatitis B
39. Hepatitis B virus and hepatocellular carcinoma
40. Immune pathogenesis of hepatocellular carcinoma
41. The role of hepatitis B (HBV) in the development of hepatocellular carcinoma
42. Hepatitis B virus and liver cancer: Unanswered questions
43. Molecular mechanisms of hepatitis B and C viruses related to liver carcinogenesis
44. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma
45. Transactivation of cellular genes by hepatitis B virus proteins: A possible mechanism of hepatocarcinogenesis
46. Expression of mutated hepatitis B virus X genes in Human hepatocellular carcinomas
47. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis
48. The preS2 activators of the hepatitis B virus: Activators of tumor promoter pathways
49. Ser-249 mutations in plasma DNA of patients with hepatocarcinoma from the Gambia
50. Antiviral therapy for chronic hepatitis B and C. Which patients are likely to benefit from which agents?
51. Therapy of chronic viral hepatitis: A critical review
52. Chronic hepatitis B: New therapies on the horizon?
53. Chronic hepatitis B infection: Treatment strategies for the next millenium
54. New therapies for the treatment of chronic hepatitis B infection
55. Chronic hepatitis B, biological basis for new therapeutic strategies
56. Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
57. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomized trial
58. Treatment of chronic viral hepatitis
59. Interferons in the management of viral hepatitis
60. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
61. Combinational screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus
62. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences
63. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
64. A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis
65. Plasma-derived hepatitis B vaccine: A breakthrough in preventive medicine
66. Purified and inactivated human hepatitis B vaccine. Progress report
67. Vaccine against human hepatitis B
68. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report
69. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
70. Human hepatitis B vaccine from recombinant yeast
71. Yeast recombinant hepatitis B vaccine
72. Three decades of hepatitis vaccinology in historic perspective. A paradigm of successful pursuits
73. Immunology vaccinology and pathogenesis of hepatitis B
74. The heritage of hepatitis B vaccine
75. Are booster immunizations needed for lifelong hepatitis B immunity?
76. Strategies to prevent and control hepatitis B and C virus infections: A global perspective
77. Status of hepatitis B immunization programmes in 1998
78. Nationwide vaccination: A success story in Taiwan
79. Disease control priorities in developing countries: An overview
80. World Bank's cure for donor fatigue
81. Global alliance for vaccines and immunization - A millennium change
82. The global alliance for vaccines and immunization